Liminatus Pharma appoints Eric Sunghee Kang as chief corporate strategist
LIMN•Liminatus Pharma appointed Eric Sunghee Kang chief corporate strategist on Nov. 16, 2026, effective immediately.
1. New strategist appointed
Kang will report to CEO Chris Kim and oversee corporate finance, capital markets strategy and new business initiatives. He has led Seoul-based Quantinum Investment since 2022 and served as head of strategy and finance at a Nasdaq-listed company in 2025.




